Cargando…

Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells

Intracellular photosensitiser localisation significantly influences the mechanism of response to photodynamic therapy (PDT), since the primary sites of damage are closely related to the specific sensitiser distribution. Foscan® subcellular localisation in the MCF-7 human adenocarcinoma cell line has...

Descripción completa

Detalles Bibliográficos
Autores principales: Teiten, M-H, Bezdetnaya, L, Morlière, P, Santus, R, Guillemin, F
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376781/
https://www.ncbi.nlm.nih.gov/pubmed/12556974
http://dx.doi.org/10.1038/sj.bjc.6600664
_version_ 1782154738124455936
author Teiten, M-H
Bezdetnaya, L
Morlière, P
Santus, R
Guillemin, F
author_facet Teiten, M-H
Bezdetnaya, L
Morlière, P
Santus, R
Guillemin, F
author_sort Teiten, M-H
collection PubMed
description Intracellular photosensitiser localisation significantly influences the mechanism of response to photodynamic therapy (PDT), since the primary sites of damage are closely related to the specific sensitiser distribution. Foscan® subcellular localisation in the MCF-7 human adenocarcinoma cell line has been studied by means of confocal microscopy and microspectrofluorometry. The fluorescence topographic profiles recorded after cells costained with Foscan® and organelle-specific fluorescent probes revealed that Foscan® presents low localisation in lysosomes and a weak accumulation in mitochondria. Alternatively, the Foscan® fluorescence topographic profile turned out to colocalise perfectly with that obtained for the endoplasmic reticulum (ER) and the Golgi apparatus. The patterns of fluorescence derived from confocal microscopy studies were consistent with predominant localisation of Foscan® in these organelles. Furthermore, evaluation of enzymatic activity of selected organelles immediately after laser light irradiation (650 nm) indicated the Golgi apparatus and ER as the primary damaged sites resulting from Foscan®-mediated PDT in the MCF-7 cell line. To our knowledge, this is the first study to demonstrate unambiguously that the ER and the Golgi apparatus are preferential sites of Foscan® accumulation.
format Text
id pubmed-2376781
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23767812009-09-10 Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells Teiten, M-H Bezdetnaya, L Morlière, P Santus, R Guillemin, F Br J Cancer Experimental Therapeutics Intracellular photosensitiser localisation significantly influences the mechanism of response to photodynamic therapy (PDT), since the primary sites of damage are closely related to the specific sensitiser distribution. Foscan® subcellular localisation in the MCF-7 human adenocarcinoma cell line has been studied by means of confocal microscopy and microspectrofluorometry. The fluorescence topographic profiles recorded after cells costained with Foscan® and organelle-specific fluorescent probes revealed that Foscan® presents low localisation in lysosomes and a weak accumulation in mitochondria. Alternatively, the Foscan® fluorescence topographic profile turned out to colocalise perfectly with that obtained for the endoplasmic reticulum (ER) and the Golgi apparatus. The patterns of fluorescence derived from confocal microscopy studies were consistent with predominant localisation of Foscan® in these organelles. Furthermore, evaluation of enzymatic activity of selected organelles immediately after laser light irradiation (650 nm) indicated the Golgi apparatus and ER as the primary damaged sites resulting from Foscan®-mediated PDT in the MCF-7 cell line. To our knowledge, this is the first study to demonstrate unambiguously that the ER and the Golgi apparatus are preferential sites of Foscan® accumulation. Nature Publishing Group 2003-01-13 2003-01-28 /pmc/articles/PMC2376781/ /pubmed/12556974 http://dx.doi.org/10.1038/sj.bjc.6600664 Text en Copyright © 2003 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Experimental Therapeutics
Teiten, M-H
Bezdetnaya, L
Morlière, P
Santus, R
Guillemin, F
Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells
title Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells
title_full Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells
title_fullStr Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells
title_full_unstemmed Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells
title_short Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells
title_sort endoplasmic reticulum and golgi apparatus are the preferential sites of foscan® localisation in cultured tumour cells
topic Experimental Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376781/
https://www.ncbi.nlm.nih.gov/pubmed/12556974
http://dx.doi.org/10.1038/sj.bjc.6600664
work_keys_str_mv AT teitenmh endoplasmicreticulumandgolgiapparatusarethepreferentialsitesoffoscanlocalisationinculturedtumourcells
AT bezdetnayal endoplasmicreticulumandgolgiapparatusarethepreferentialsitesoffoscanlocalisationinculturedtumourcells
AT morlierep endoplasmicreticulumandgolgiapparatusarethepreferentialsitesoffoscanlocalisationinculturedtumourcells
AT santusr endoplasmicreticulumandgolgiapparatusarethepreferentialsitesoffoscanlocalisationinculturedtumourcells
AT guilleminf endoplasmicreticulumandgolgiapparatusarethepreferentialsitesoffoscanlocalisationinculturedtumourcells